Featured Research

from universities, journals, and other organizations

Certain medications associated with increased risk of urinary retention in men with COPD

Date:
May 23, 2011
Source:
JAMA and Archives Journals
Summary:
Men with chronic obstructive pulmonary disease (COPD) who are treated with inhaled anticholinergic drugs appear to have an increased risk of developing urinary retention (inability to urinate), according to a new report.

Men with chronic obstructive pulmonary disease (COPD) who are treated with inhaled anticholinergic drugs appear to have an increased risk of developing urinary retention (inability to urinate), according to a report in the May 23 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. The article is part of the journal's Less Is More series.

Related Articles


Chronic obstructive pulmonary disease is a progressive respiratory disorder in which inflammation or blockage in the lungs makes breathing difficult. According to background information in the article, it affects 10 percent of people age 40 years and older. Inhaled anticholinergic medications (IACs) help the airway's muscles relax and reduce obstructions in airflow. However, the authors note, "there is uncertainty about whether IACs cause clinically important systemic anticholinergic effects."

In previous clinical trials of these medications, a connection was noticed with acute urinary retention (AUR), an inability to urinate which is considered a medical emergency. The authors note that AUR can lead to serious complications. "Understanding the risk of AUR associated with IAC therapy would help to identify those at risk for this complication," they explain.

Anne Stephenson, M.D., Ph.D., from St. Michael's Hospital, Toronto, Canada, and colleagues conducted a study using data from Ontario's universal health insurance program. They selected individuals ages 66 years or older with COPD and searched the data for treatment with IACs and development of AUR between April 2003 and March 2009. Researchers further segmented the data by patients' IAC regimens.

Among the original cohort of 565,073 patients with COPD, a total of 9,432 men and 1,806 women developed AUR. "This relationship was not statistically significant in women," the researchers write, but was significant in men. Among IAC users, the odds of AUR were about 40 percent higher in men who had been using IACs for one month or less and about 80 percent higher in men with an enlarged prostate gland. Simultaneous use of both short-acting and long-acting IACs significantly elevated men's odds of AUR.

"Physicians should highlight for patients the possible connection between urinary symptoms and inhaled respiratory medication use to ensure that changes in urinary flow (ie, incomplete voiding, urinary incontinence, and decreased urinary flow) are reported to the physician prescribing the IAC," explain the authors. They add that the odds of AUR may be reduced by taking the lowest effective dose of IACs and avoiding combinations that raise a patient's risk. "Physicians and the public need to be aware of the potential for this significant adverse event," they conclude, "so that preventive measures and potential therapy can be considered."

Commentary: Deciding Whether, and When, to Treat COPD with IACs

In a commentary accompanying the article, Sonal Singh, M.D., M.P.H., from The Johns Hopkins University in Baltimore and Curt D. Furberg, M.D., Ph.D., from Wake Forest University, Winston-Salem, N.C., note that IACs do not completely stall the progress of COPD or keep patients alive longer. "Therefore, information on serious adverse effects associated with IACs can potentially alter their benefit-harm assessment," they observe. Besides the urological complications found by Stephenson and colleagues, previous studies have connected this category of drugs with cardiovascular events and mortality. An alternate therapy, corticosteroids, has been associated with an increased risk of serious pneumonia. Ultimately, write Singh and Furberg, "Physicians should inform patients with COPD about the risk of AUR associated with IACs and determine the optimal choice of therapy for their patients after eliciting patient preferences for various patient-oriented outcomes in a shared decision-making context."


Story Source:

The above story is based on materials provided by JAMA and Archives Journals. Note: Materials may be edited for content and length.


Journal References:

  1. Anne Stephenson; Dallas Seitz; Chaim M. Bell; Andrea Gruneir; Andrea S. Gershon; Peter C. Austin; Longdi Fu; Geoffrey M. Anderson; Paula A. Rochon; Sudeep S. Gill. Inhaled Anticholinergic Drug Therapy and the Risk of Acute Urinary Retention in Chronic Obstructive Pulmonary Disease: A Population-Based Study. Archives of Internal Medicine, 2011; 171 (10): 914-920 DOI: 10.1001/archinternmed.2011.170
  2. Sonal Singh; Curt D. Furberg. Inhaled Anticholinergics for Chronic Obstructive Pulmonary Disease: Comment on 'Inhaled Anticholinergic Drug Therapy and the Risk of Acute Urinary Retention in Chronic Obstructive Pulmonary Disease'. Archives of Internal Medicine, 2011; 171 (10): 920-922 DOI: 10.1001/archinternmed.2011.171

Cite This Page:

JAMA and Archives Journals. "Certain medications associated with increased risk of urinary retention in men with COPD." ScienceDaily. ScienceDaily, 23 May 2011. <www.sciencedaily.com/releases/2011/05/110523161153.htm>.
JAMA and Archives Journals. (2011, May 23). Certain medications associated with increased risk of urinary retention in men with COPD. ScienceDaily. Retrieved November 27, 2014 from www.sciencedaily.com/releases/2011/05/110523161153.htm
JAMA and Archives Journals. "Certain medications associated with increased risk of urinary retention in men with COPD." ScienceDaily. www.sciencedaily.com/releases/2011/05/110523161153.htm (accessed November 27, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, November 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com
From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

Newsy (Nov. 25, 2014) The US FDA is announcing new calorie rules on Tuesday that will require everywhere from theaters to vending machines to include calorie counts. Video provided by Newsy
Powered by NewsLook.com
Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Newsy (Nov. 25, 2014) Need another reason to eat yogurt every day? Researchers now say it could reduce a person's risk of developing type 2 diabetes. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins